Drug Development

Drug development: describes the process of developing a new drug that energetically targets a specific weakness in a cell. The process consist of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery.

Webinars

JAN 26, 2021 8:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

C.E. CREDITS

JAN 26, 2021 8:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

High-throughput CRISPR editing using the Onyx™ platform identifies...

Date: January 26, 2021 Time: 9:00am (PST), 12:00pm (EST) Over the past years, CRISPR/Cas genome editing has quickly become the method of choice for genetic manipulation, owing to its ease-of...

Speaker: Liselot Dewachter, PhD , Laura Klitten, Ph.D.

Sponsored By: Inscripta

C.E. CREDITS

Preclinical evaluation of novel OT-analogs for the potential treatment...

As pharmaceutical companies have reduced or eliminated neuroscience drug development due to high costs and low approval rates, the economic and healthcare burden of CNS disorders in the Unit...

Speaker: Marsha Pierce, PhD

Presented at: Drug Discovery & Development 2021

C.E. CREDITS

The Comprehensive A.I.-Driven Genomic Landscape for ALS - Implications...

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease affecting approximately 1 in 50,000 people worldwide. About 10% of these cases are found to have a hereditary component, bu...

Speaker: Mark Kiel, MD, PhD

Presented at: Drug Discovery & Development 2021

C.E. CREDITS

The development and application of TRUPATH biosensors to the study...

G-protein-coupled receptors (GPCRs) remain major drug targets, despite an incomplete understanding of how they signal through 16 non-visual G-protein signal transducers (collectively named t...

Speaker: Reid Olsen, PhD, Pharmacology, Head of GPCR Pharmacology

Presented at: Drug Discovery & Development 2021

C.E. CREDITS

Nonclinical COVID-19 Vaccine Development During a Pandemic

The COVID-19 pandemic changed all of our lives in 2020. Development of a COVID-19 vaccine required some re-thinking of the standard vaccine development paradigm. The webinar will cover noncl...

Speaker: Cynthia Rohde, PhD, DABT

Presented at: Drug Discovery & Development 2021

C.E. CREDITS

Multi-diagnostic approaches for patient selection in immuno-oncology

...

Speaker: Cindy Spittle

Presented at: Drug Discovery & Development 2021

C.E. CREDITS

Evolution of a Platform-Based Non-Clinical Safety Assessment Approach...

...

Speaker: Joseph J. Senn, PhD, DABT

Presented at: Drug Discovery & Development 2021

FEB 24, 2021 7:30 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

C.E. CREDITS

FEB 24, 2021 7:30 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

Keynote Presentation: The biomarker to companion diagnostic continuum:...

Specific biomarker assays are included in an increasing number of drug labels, with uses ranging from prediction of adverse events to providing insights on efficacy for patient populations....

Speaker: Steven M. Anderson, PhD

Presented at: Drug Discovery & Development 2021

FEB 24, 2021 9:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

C.E. CREDITS

FEB 24, 2021 9:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

Keynote Panel Presentation: Biomarker assays - bioanalytical meets...

Reliable diagnostic, prognostic, predictive, pharmacodynamic, and pharmacokinetic biomarkers are critical to assure correct patient selection, drug dosing, and monitoring. Being able to iden...

Speaker: Andrew Roche, PhD , Roger Hayes, PhD

Presented at: Drug Discovery & Development 2021

C.E. CREDITS

Researching Early Detection of Ovarian and Endometrial Cancer...

Due to unforeseen circumstances, this webinar has been postponed to a further date. Most deaths from ovarian and endometrial cancer are due to high-grade subtypes that metastasize before the...

Speaker: Lucy Gilbert, MD, MSc, FRCOG , Ionnnes Ragoussis, Ph.D.

Sponsored By: Agilent

JAN 21, 2021 8:00 AM PST

JAN 21, 2021 8:00 AM PST

Critical reagent characterization for regulated bioassays accelerated...

Date: January 21, 2021 Time: 8:00am (PST), 11:00am (EST) Today, critical reagent characterization is a key component in the overall workflow to establish robust ligand binding assays (e.g.,...

Speaker: Ron Bowsher , Adam Kinne , Kevin Lance, Ph.D.

Sponsored By: Unchained Labs

DEC 17, 2020 9:00 AM PST

C.E. CREDITS

DEC 17, 2020 9:00 AM PST

Advancing Cell Biology with Cryo-Correlative Microscopy

Date: December 17, 2020 Time: 9:00am (PST), 12:00pm (EST) Correlative light and electron microscopy (CLEM) advances biological discoveries by merging different microscopes and imaging moda...

Speaker: Elizabeth Wright, Ph.D. , Jae Yang, Ph.D. , Bryan Sibert, Ph.D. , Joseph Kim

Sponsored By: Leica Microsystems, Alveole

DEC 10, 2020 8:00 AM PST

DEC 10, 2020 8:00 AM PST

Simple and Fast Charge Variants Analysis of mAbs by CZE

Date: December 10, 2020 Time: 8:00am (PST), 11:00am (EST) As you face increasingly shortened timelines to bring new drugs to market, you find yourself strained to finalize analytical methods...

Speaker: Yan He, Ph.D.

Sponsored By: SCIEX

DEC 09, 2020 7:00 AM PST

C.E. CREDITS

DEC 09, 2020 7:00 AM PST

Characterization of RNA therapeutics from small to large

Date: December 9, 2020 Time: 7:00am (PST), 10:00am (EST) In this talk we will discuss the new analytical approaches to characterize RNA molecules from small oligonucleotides to larger messen...

Speaker: Stephen Lock, PhD

Sponsored By: SCIEX

DEC 07, 2020 9:00 AM PST

DEC 07, 2020 9:00 AM PST

Rapid hyper-plex staining and simultaneous imaging for immunophenotyping...

Date: December 7, 2020 Time: 9:00am (PST), 12:00pm (EST) The simultaneous detection of biomarkers on tissue samples plays a fundamental role in the study of the tumor microenvironment. Multi...

Speaker: Diego Dupouy, Ph.D.

Sponsored By: Lunaphore

DEC 03, 2020 4:30 PM PST

C.E. CREDITS

DEC 03, 2020 4:30 PM PST

An Iterative Approach to Structure-based in silico to in vivo...

This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...

Speaker: Garth Ehrlich, PhD, FAAAS

Presented at: Coronavirus Virtual Event Series

DEC 03, 2020 12:00 PM PST

C.E. CREDITS

DEC 03, 2020 12:00 PM PST

Advancing SARS-CoV-2 Diagnostics Through Standardization and Quantitation

The COVID-19 pandemic continues to have a grip on worldwide health and global economics. Advancing molecular diagnostics is central to the diagnosis and prevention efforts surrounding the de...

Speaker: Russell Garlick, PhD , Marc Salit, PhD

Presented at: Coronavirus Virtual Event SeriesSponsored By: LGC Seracare

DEC 02, 2020 8:00 AM PST

C.E. CREDITS

DEC 02, 2020 8:00 AM PST

Optimize your bioprocess - From shaker to bioreactor

DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...

Speaker: Ines Hartmann , David Solbach

Sponsored By: Eppendorf

NOV 20, 2020 8:00 AM PST

C.E. CREDITS

NOV 20, 2020 8:00 AM PST

Efficiency to Confidence with High Resolution Accurate Mass Spectrometers:...

DATE: November 20, 2020 TIME: 8am PDT, 11am EDT Insulin-like growth factor-1 (IGF-1) measurement by high-resolution accurate mass-mass spectrometry (HRAM) is replacing IGF-1 immunoassays and...

Speaker: Tony Maus

Sponsored By: Thermo Fisher Scientific

NOV 19, 2020 9:00 AM PST

C.E. CREDITS

NOV 19, 2020 9:00 AM PST

From Protein Structures to Drug Discovery: Novel therapeutic opportunities.

DATE: November 19, 2020 TIME: 9:00am PT, 12am ET Knowledge of the three-dimensional structure of therapeutically relevant targets has become an essential step in the pipeline of drug discove...

Speaker: Amal Hassan Ali

Sponsored By: Thermo Fisher Scientific

NOV 19, 2020 8:00 AM PST

C.E. CREDITS

NOV 19, 2020 8:00 AM PST

From discovery to functional assays: therapeutic antibody research...

Date: November 19, 2020 Time: 8:00am PST, 11:00am EST Monoclonal antibody-based drugs have shown great potential as a treatment for several cancers. At Miltenyi Biotec, we offer a complete wo...

Speaker: Susanne Bethke

Sponsored By: Miltenyi Biotec

NOV 18, 2020 8:00 AM PST

C.E. CREDITS

NOV 18, 2020 8:00 AM PST

Whole-organ mapping using AI and light sheet microscopy

DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...

Speaker: Ali Ertürk

Sponsored By: Miltenyi Biotec

NOV 16, 2020 8:00 AM PST

C.E. CREDITS

NOV 16, 2020 8:00 AM PST

Targeted single-cell RNA sequencing enables genome-scale CRISPR...

Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...

Speaker: Wieland Keilholz, Ph.D. , Pawel Zajac, Ph.D. , Dr. Tilmann Buerckstuemmer

Sponsored By: Illumina

NOV 12, 2020 10:00 AM PST

NOV 12, 2020 10:00 AM PST

FcRn Affinity Column Chromatography for Therapeutic mAb Characterization

Date: November 12, 2020 Time: 10:00am (PST), 1:00pm (EST) Fc receptor based affinity chromatography is a new emerging field of Fc functionality analytics. FcRn affinity columns separate anti...

Speaker: Tilman Schlothauer, Ph.D

Sponsored By: Roche CustomBiotech

JAN 26, 2021 8:00 AM PST

Add to Calendar Select one of the following:

iCal

Google Calendar

Outlook Calendar

Yahoo Calendar

C.E. CREDITS

High-throughput CRISPR editing using the Onyx™ platform identifies essential residues in proteins

JAN 26, 2021 8:00 AM PST

Add to Calendar Select one of the following:

iCal

Google Calendar

Outlook Calendar

Yahoo Calendar

High-throughput CRISPR editing using the Onyx™ platform identifies...

Date: January 26, 2021 Time: 9:00am (PST), 12:00pm (EST) Over the past years, CRISPR/Cas genome editing has quickly become the method of choice for genetic manipulation, owing to its ease-of...

C.E. CREDITS

Preclinical evaluation of novel OT-analogs for the potential treatment...

As pharmaceutical companies have reduced or eliminated neuroscience drug development due to high costs and low approval rates, the economic and healthcare burden of CNS disorders in the Unit...

C.E. CREDITS

The Comprehensive A.I.-Driven Genomic Landscape for ALS - Implications...

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease affecting approximately 1 in 50,000 people worldwide. About 10% of these cases are found to have a hereditary component, bu...

C.E. CREDITS

The development and application of TRUPATH biosensors to the study...

G-protein-coupled receptors (GPCRs) remain major drug targets, despite an incomplete understanding of how they signal through 16 non-visual G-protein signal transducers (collectively named t...

C.E. CREDITS

Nonclinical COVID-19 Vaccine Development During a Pandemic

The COVID-19 pandemic changed all of our lives in 2020. Development of a COVID-19 vaccine required some re-thinking of the standard vaccine development paradigm. The webinar will cover noncl...

C.E. CREDITS

Multi-diagnostic approaches for patient selection in immuno-oncology

...

C.E. CREDITS

Evolution of a Platform-Based Non-Clinical Safety Assessment Approach...

...

FEB 24, 2021 7:30 AM PST

Add to Calendar Select one of the following:

iCal

Google Calendar

Outlook Calendar

Yahoo Calendar

C.E. CREDITS

Keynote Presentation: The biomarker to companion diagnostic continuum: a road map for the delivery of precision medicine

FEB 24, 2021 7:30 AM PST

Add to Calendar Select one of the following:

iCal

Google Calendar

Outlook Calendar

Yahoo Calendar

Keynote Presentation: The biomarker to companion diagnostic continuum:...

Specific biomarker assays are included in an increasing number of drug labels, with uses ranging from prediction of adverse events to providing insights on efficacy for patient populations....

FEB 24, 2021 9:00 AM PST

Add to Calendar Select one of the following:

iCal

Google Calendar

Outlook Calendar

Yahoo Calendar

C.E. CREDITS

Keynote Panel Presentation: Biomarker assays - bioanalytical meets CLIA

FEB 24, 2021 9:00 AM PST

Add to Calendar Select one of the following:

iCal

Google Calendar

Outlook Calendar

Yahoo Calendar

Keynote Panel Presentation: Biomarker assays - bioanalytical meets...

Reliable diagnostic, prognostic, predictive, pharmacodynamic, and pharmacokinetic biomarkers are critical to assure correct patient selection, drug dosing, and monitoring. Being able to iden...

C.E. CREDITS

Researching Early Detection of Ovarian and Endometrial Cancer...

Due to unforeseen circumstances, this webinar has been postponed to a further date. Most deaths from ovarian and endometrial cancer are due to high-grade subtypes that metastasize before the...

JAN 21, 2021 8:00 AM PST

Critical reagent characterization for regulated bioassays accelerated...

Date: January 21, 2021 Time: 8:00am (PST), 11:00am (EST) Today, critical reagent characterization is a key component in the overall workflow to establish robust ligand binding assays (e.g.,...

Speaker: Ron Bowsher , Adam Kinne , Kevin Lance, Ph.D.

Sponsored By: Unchained Labs

DEC 17, 2020 9:00 AM PST

C.E. CREDITS

DEC 17, 2020 9:00 AM PST

Advancing Cell Biology with Cryo-Correlative Microscopy

Date: December 17, 2020 Time: 9:00am (PST), 12:00pm (EST) Correlative light and electron microscopy (CLEM) advances biological discoveries by merging different microscopes and imaging moda...

Speaker: Elizabeth Wright, Ph.D. , Jae Yang, Ph.D. , Bryan Sibert, Ph.D. , Joseph Kim

Sponsored By: Leica Microsystems, Alveole

DEC 10, 2020 8:00 AM PST

Simple and Fast Charge Variants Analysis of mAbs by CZE

Date: December 10, 2020 Time: 8:00am (PST), 11:00am (EST) As you face increasingly shortened timelines to bring new drugs to market, you find yourself strained to finalize analytical methods...

DEC 09, 2020 7:00 AM PST

C.E. CREDITS

DEC 09, 2020 7:00 AM PST

Characterization of RNA therapeutics from small to large

Date: December 9, 2020 Time: 7:00am (PST), 10:00am (EST) In this talk we will discuss the new analytical approaches to characterize RNA molecules from small oligonucleotides to larger messen...

DEC 07, 2020 9:00 AM PST

Rapid hyper-plex staining and simultaneous imaging for immunophenotyping...

Date: December 7, 2020 Time: 9:00am (PST), 12:00pm (EST) The simultaneous detection of biomarkers on tissue samples plays a fundamental role in the study of the tumor microenvironment. Multi...

DEC 03, 2020 4:30 PM PST

C.E. CREDITS

DEC 03, 2020 4:30 PM PST

An Iterative Approach to Structure-based in silico to in vivo...

This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...

DEC 03, 2020 12:00 PM PST

C.E. CREDITS

DEC 03, 2020 12:00 PM PST

Advancing SARS-CoV-2 Diagnostics Through Standardization and Quantitation

The COVID-19 pandemic continues to have a grip on worldwide health and global economics. Advancing molecular diagnostics is central to the diagnosis and prevention efforts surrounding the de...

DEC 02, 2020 8:00 AM PST

C.E. CREDITS

DEC 02, 2020 8:00 AM PST

Optimize your bioprocess - From shaker to bioreactor

DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...

NOV 20, 2020 8:00 AM PST

C.E. CREDITS

NOV 20, 2020 8:00 AM PST

Efficiency to Confidence with High Resolution Accurate Mass Spectrometers:...

DATE: November 20, 2020 TIME: 8am PDT, 11am EDT Insulin-like growth factor-1 (IGF-1) measurement by high-resolution accurate mass-mass spectrometry (HRAM) is replacing IGF-1 immunoassays and...

NOV 19, 2020 9:00 AM PST

C.E. CREDITS

NOV 19, 2020 9:00 AM PST

From Protein Structures to Drug Discovery: Novel therapeutic opportunities.

DATE: November 19, 2020 TIME: 9:00am PT, 12am ET Knowledge of the three-dimensional structure of therapeutically relevant targets has become an essential step in the pipeline of drug discove...

NOV 19, 2020 8:00 AM PST

C.E. CREDITS

NOV 19, 2020 8:00 AM PST

From discovery to functional assays: therapeutic antibody research...

Date: November 19, 2020 Time: 8:00am PST, 11:00am EST Monoclonal antibody-based drugs have shown great potential as a treatment for several cancers. At Miltenyi Biotec, we offer a complete wo...

NOV 18, 2020 8:00 AM PST

C.E. CREDITS

NOV 18, 2020 8:00 AM PST

Whole-organ mapping using AI and light sheet microscopy

DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...

NOV 16, 2020 8:00 AM PST

C.E. CREDITS

NOV 16, 2020 8:00 AM PST

Targeted single-cell RNA sequencing enables genome-scale CRISPR...

Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...

Speaker: Wieland Keilholz, Ph.D. , Pawel Zajac, Ph.D. , Dr. Tilmann Buerckstuemmer

Sponsored By: Illumina

NOV 12, 2020 10:00 AM PST

FcRn Affinity Column Chromatography for Therapeutic mAb Characterization

Date: November 12, 2020 Time: 10:00am (PST), 1:00pm (EST) Fc receptor based affinity chromatography is a new emerging field of Fc functionality analytics. FcRn affinity columns separate anti...

Load More